Veritas Aortic Solutions, a Costa Mesa-based medical device company, today announced the closing of $12 million in seed funding.
Funds from the round, which had participation from investors including Cedars-Sinai Intellectual Property Company, will support the development of the company’s non-surgical device to treat high-risk root and ascending aortic diseases.
“We are honored to have the support of seasoned MedTech investors, leading physicians, and a world-class healthcare organization like Cedars-Sinai to accelerate our development and bring this technology towards its first clinical application,” J. Brent Ratz, co-founder and chief executive of Veritas, said in a statement.
Related Healthcare Stories:
